These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35888599)

  • 1. DNA Methylation by Bisulfite Next-Generation Sequencing for MLH1 and MGMT in Oral Squamous Cell Carcinomas and Potentially Malignant Disorders: An Integrative Analysis towards Field Cancerization.
    Padin-Iruegas E; Chamorro-Petronacci CM; Sines-Cajade I; Lorenzo-Pouso AI; Blanco-Carrión A; Pérez-Jardón A; Gándara-Vila P; Pérez-Sayans M
    Medicina (Kaunas); 2022 Jun; 58(7):. PubMed ID: 35888599
    [No Abstract]   [Full Text] [Related]  

  • 2. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter region hypermethylation and mRNA expression of MGMT and p16 genes in tissue and blood samples of human premalignant oral lesions and oral squamous cell carcinoma.
    Bhatia V; Goel MM; Makker A; Tewari S; Yadu A; Shilpi P; Kumar S; Agarwal SP; Goel SK
    Biomed Res Int; 2014; 2014():248419. PubMed ID: 24991542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MGMT and MLH1 methylation in Helicobacter pylori-infected children and adults.
    Alvarez MC; Santos JC; Maniezzo N; Ladeira MS; da Silva AL; Scaletsky IC; Pedrazzoli J; Ribeiro ML
    World J Gastroenterol; 2013 May; 19(20):3043-51. PubMed ID: 23716983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter hypermethylation of CDKN2A, MGMT, MLH1, and DAPK genes in laryngeal squamous cell carcinoma and their associations with clinical profiles of the patients.
    Pierini S; Jordanov SH; Mitkova AV; Chalakov IJ; Melnicharov MB; Kunev KV; Mitev VI; Kaneva RP; Goranova TE
    Head Neck; 2014 Aug; 36(8):1103-8. PubMed ID: 23804521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant gene promoter methylation of E-cadherin, p16
    Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
    Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of MTHFR Genetic Background on p16 and MGMT Methylation in Oral Squamous Cell Cancer.
    Ferlazzo N; Currò M; Zinellu A; Caccamo D; Isola G; Ventura V; Carru C; Matarese G; Ientile R
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28353639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of methylation markers for the prediction of nodal metastasis in oral and oropharyngeal squamous cell carcinoma.
    Melchers LJ; Clausen MJ; Mastik MF; Slagter-Menkema L; van der Wal JE; Wisman GB; Roodenburg JL; Schuuring E
    Epigenetics; 2015; 10(9):850-60. PubMed ID: 26213212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells.
    Wang W; Li X; Wang F; Sun XY
    J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis.
    Mikeska T; Bock C; El-Maarri O; Hübner A; Ehrentraut D; Schramm J; Felsberg J; Kahl P; Büttner R; Pietsch T; Waha A
    J Mol Diagn; 2007 Jul; 9(3):368-81. PubMed ID: 17591937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of MLH1 and MGMT expression and promoter methylation with genomic instability in patients with thyroid carcinoma.
    Santos JC; Bastos AU; Cerutti JM; Ribeiro ML
    BMC Cancer; 2013 Feb; 13():79. PubMed ID: 23414134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method.
    Tournier B; Chapusot C; Courcet E; Martin L; Lepage C; Faivre J; Piard F
    BMC Cancer; 2012 Jan; 12():12. PubMed ID: 22243995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
    Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
    Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High levels of circulating folate concentrations are associated with DNA methylation of tumor suppressor and repair genes
    Sanchez H; Hossain MB; Lera L; Hirsch S; Albala C; Uauy R; Broberg K; Ronco AM
    Clin Epigenetics; 2017; 9():74. PubMed ID: 28748002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotor hypermethylated genes: Prospective diagnostic biomarkers in oral cancerogenesis.
    Dvojakovska S; Popovic-Monevska D; Grcev A; Pancevski G; Benedetti A; Popovski V; Dimovski A; Stamatoski A
    J Craniomaxillofac Surg; 2018 Oct; 46(10):1737-1740. PubMed ID: 30100382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
    Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
    Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
    Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events.
    de Vogel S; Weijenberg MP; Herman JG; Wouters KA; de Goeij AF; van den Brandt PA; de Bruïne AP; van Engeland M
    Ann Oncol; 2009 Jul; 20(7):1216-22. PubMed ID: 19164452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG island methylation of the MLH1, MGMT, DAPK, and CASP8 genes in cancerous and adjacent noncancerous stomach tissues.
    Kupčinskaitė-Noreikienė R; Skiecevičienė J; Jonaitis L; Ugenskienė R; Kupčinskas J; Markelis R; Baltrėnas V; Sakavičius L; Semakina I; Grižas S; Juozaitytė E
    Medicina (Kaunas); 2013; 49(8):361-6. PubMed ID: 24509146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.